Cognex Co. (NASDAQ:CGNX) Shares Purchased by Parametric Portfolio Associates LLC

Share on StockTwits

Parametric Portfolio Associates LLC boosted its holdings in Cognex Co. (NASDAQ:CGNX) by 11.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 329,995 shares of the scientific and technical instruments company’s stock after buying an additional 34,634 shares during the quarter. Parametric Portfolio Associates LLC’s holdings in Cognex were worth $16,213,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Pinebridge Investments L.P. lifted its stake in Cognex by 0.9% during the second quarter. Pinebridge Investments L.P. now owns 26,388 shares of the scientific and technical instruments company’s stock worth $1,266,000 after purchasing an additional 232 shares during the last quarter. Circle Wealth Management LLC raised its holdings in Cognex by 4.6% during the second quarter. Circle Wealth Management LLC now owns 7,686 shares of the scientific and technical instruments company’s stock worth $369,000 after purchasing an additional 336 shares in the last quarter. Schwab Charitable Fund raised its holdings in Cognex by 8.9% during the third quarter. Schwab Charitable Fund now owns 4,790 shares of the scientific and technical instruments company’s stock worth $235,000 after purchasing an additional 390 shares in the last quarter. Captrust Financial Advisors raised its holdings in Cognex by 12.0% during the second quarter. Captrust Financial Advisors now owns 3,767 shares of the scientific and technical instruments company’s stock worth $181,000 after purchasing an additional 405 shares in the last quarter. Finally, Cornerstone Advisors Inc. lifted its position in shares of Cognex by 42.7% during the 3rd quarter. Cornerstone Advisors Inc. now owns 1,408 shares of the scientific and technical instruments company’s stock worth $69,000 after buying an additional 421 shares during the last quarter. 91.37% of the stock is currently owned by hedge funds and other institutional investors.

In other Cognex news, Director Theodor Krantz sold 30,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $51.87, for a total transaction of $1,556,100.00. Following the completion of the sale, the director now directly owns 52,500 shares of the company’s stock, valued at approximately $2,723,175. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Robert Willett sold 19,408 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $53.86, for a total value of $1,045,314.88. Following the sale, the chief executive officer now directly owns 19,408 shares of the company’s stock, valued at $1,045,314.88. The disclosure for this sale can be found here. Insiders have sold a total of 396,202 shares of company stock worth $20,619,219 over the last three months. 5.60% of the stock is currently owned by insiders.

A number of research firms recently commented on CGNX. Daiwa Capital Markets set a $53.00 target price on shares of Cognex and gave the company a “hold” rating in a research report on Tuesday, September 24th. ValuEngine upgraded shares of Cognex from a “strong sell” rating to a “sell” rating in a research note on Tuesday, December 3rd. BidaskClub cut shares of Cognex from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 14th. Morgan Stanley set a $47.00 price objective on shares of Cognex and gave the company a “hold” rating in a research note on Friday, November 1st. Finally, Robert W. Baird raised their price objective on Cognex from $42.00 to $47.00 and gave the stock a “neutral” rating in a report on Monday, September 23rd. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $50.10.

CGNX stock opened at $51.39 on Friday. The company has a current ratio of 7.71, a quick ratio of 6.90 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $8.78 billion, a P/E ratio of 41.44 and a beta of 2.07. The business has a 50 day simple moving average of $51.47 and a 200-day simple moving average of $46.70. Cognex Co. has a twelve month low of $34.88 and a twelve month high of $57.31.

Cognex (NASDAQ:CGNX) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.03. Cognex had a net margin of 22.55% and a return on equity of 14.21%. The business had revenue of $183.33 million for the quarter, compared to analysts’ expectations of $177.78 million. During the same period in the previous year, the company posted $0.45 EPS. The company’s quarterly revenue was down 21.1% on a year-over-year basis. Research analysts predict that Cognex Co. will post 0.82 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a dividend of $0.055 per share. The ex-dividend date of this dividend was Thursday, November 14th. This represents a $0.22 dividend on an annualized basis and a yield of 0.43%. This is a boost from Cognex’s previous quarterly dividend of $0.05. Cognex’s dividend payout ratio is currently 17.74%.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Story: What is dollar cost averaging (DCA)?

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.